In nasopharyngeal carcinoma, TFAP2A regulated tumor cell growth and survival through the HIF-1α-mediated VEGF/PEDF signaling pathway, suggesting that TFAP2A could be a potential biomarker for nasopharyngeal carcinoma treatment [27]. The gene discussed is SERPINF1; the disease is nasopharyngeal carcinoma.